3D Radiotherapy Can Be Safely Combined With Sandwich Systemic Gemcitabine Chemotherapy in the Management of Pancreatic Cancer: Factors Influencing Outcome

Article ID	Journal	Published Year	Pages	File Type
8239691	International Journal of Radiation OncologyBiologyPhysics	2008	9 Pages	PDF

Abstract

This three-dimensional chemoradiotherapy regimen is safe and promising, with encouraging local control for a substantial proportion of patients, and merits testing in a randomized trial.

Keywords

Adjuvant treatment Radiotherapy Pancreatic cancer Molecular marker chemoradiation

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

3D Radiotherapy Can Be Safely Combined With Sandwich Systemic Gemcitabine Chemotherapy in the Management of Pancreatic Cancer: Factors Influencing Outcome

Authors

Nigel F.R.A.N.Z.C.R., Jennifer F.R.A.N.Z.C.R., Craig F.R.A.N.Z.C.R., Martin F.R.A.N.Z.C.R., Samuel Y. F.R.A.N.Z.C.R., Jeremy L. F.R.A.N.Z.C.R., Peter F.R.A.N.Z.C.R., Yvonne F.R.A.N.Z.C.R., Andrew F.R.A.N.Z.C.R., Susan F.R.A.N.Z.C.R., Terri B.Sc.,